These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
581 related articles for article (PubMed ID: 15649575)
1. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Kosaka K; Noda M; Kuzuya T Diabetes Res Clin Pract; 2005 Feb; 67(2):152-62. PubMed ID: 15649575 [TBL] [Abstract][Full Text] [Related]
2. [Subjects with impaired glucose tolerance returned to normal glucose status for six years had lower long-term risk of diabetes: 20 years follow up of Daqing diabetes prevention study]. Shen XX; Wang JP; Chen YY; An YL; Gong QH; Zhang B; Hong J; Shuai Y; Zhao F; Li H; Li GW Zhonghua Nei Ke Za Zhi; 2019 May; 58(5):372-376. PubMed ID: 31060146 [No Abstract] [Full Text] [Related]
3. Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance. Sakane N; Sato J; Tsushita K; Tsujii S; Kotani K; Tsuzaki K; Tominaga M; Kawazu S; Sato Y; Usui T; Kamae I; Yoshida T; Kiyohara Y; Sato S; Kuzuya H; BMC Public Health; 2011 Jan; 11(1):40. PubMed ID: 21235825 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of lifestyle intervention in adults with impaired glucose tolerance with and without impaired fasting plasma glucose: A post hoc analysis of Da Qing Diabetes Prevention Outcome Study. Gong Q; Zhang P; Wang J; Gregg EW; Cheng YJ; Li G; Bennett PH; Diabetes Obes Metab; 2021 Oct; 23(10):2385-2394. PubMed ID: 34212465 [TBL] [Abstract][Full Text] [Related]
5. A prospective study of health check examinees for the development of non-insulin-dependent diabetes mellitus: relationship of the incidence of diabetes with the initial insulinogenic index and degree of obesity. Kosaka K; Kuzuya T; Yoshinaga H; Hagura R Diabet Med; 1996 Sep; 13(9 Suppl 6):S120-6. PubMed ID: 8894495 [TBL] [Abstract][Full Text] [Related]
6. [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study]. Chen Y; Wang J; An Y; Gong Q; He Y; Zhang B; Li H; Shuai Y; Tang X; Jiang Y; Hong J; Yang W; Hu Y; Li G Zhonghua Nei Ke Za Zhi; 2015 Jan; 54(1):13-7. PubMed ID: 25877139 [TBL] [Abstract][Full Text] [Related]
7. Predictive risk factors for deterioration from normoglycemic state to type 2 diabetes mellitus or impaired glucose tolerance in a Tunisian urban population. Chihaoui M; Kanoun F; Ben Rehaiem B; Ben Brahim S; Ftouhi B; Mekaouar A; Fekih M; Mbazâd A; Zouari B; Ben Khalifa F Diabetes Metab; 2001 Sep; 27(4 Pt 1):487-95. PubMed ID: 11547223 [TBL] [Abstract][Full Text] [Related]
8. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. Saito T; Watanabe M; Nishida J; Izumi T; Omura M; Takagi T; Fukunaga R; Bandai Y; Tajima N; Nakamura Y; Ito M; Arch Intern Med; 2011 Aug; 171(15):1352-60. PubMed ID: 21824948 [TBL] [Abstract][Full Text] [Related]
9. Sustained diabetes risk reduction after real life and primary health care setting implementation of the diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Gilis-Januszewska A; Lindström J; Tuomilehto J; Piwońska-Solska B; Topór-Mądry R; Szybiński Z; Peltonen M; Schwarz PE; Windak A; Hubalewska-Dydejczyk A BMC Public Health; 2017 Feb; 17(1):198. PubMed ID: 28202029 [TBL] [Abstract][Full Text] [Related]
10. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Pan XR; Li GW; Hu YH; Wang JX; Yang WY; An ZX; Hu ZX; Lin J; Xiao JZ; Cao HB; Liu PA; Jiang XG; Jiang YY; Wang JP; Zheng H; Zhang H; Bennett PH; Howard BV Diabetes Care; 1997 Apr; 20(4):537-44. PubMed ID: 9096977 [TBL] [Abstract][Full Text] [Related]
11. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. Tuomilehto J; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Laakso M; Louheranta A; Rastas M; Salminen V; Uusitupa M; N Engl J Med; 2001 May; 344(18):1343-50. PubMed ID: 11333990 [TBL] [Abstract][Full Text] [Related]
12. Does the Effect of a 3-Year Lifestyle Intervention on Body Weight and Cardiometabolic Health Differ by Prediabetes Metabolic Phenotype? A Post Hoc Analysis of the PREVIEW Study. Zhu R; Jalo E; Silvestre MP; Poppitt SD; Handjieva-Darlenska T; Handjiev S; Huttunen-Lenz M; Mackintosh K; Stratton G; Navas-Carretero S; Pietiläinen KH; Simpson E; Macdonald IA; Muirhead R; Brand-Miller J; Fogelholm M; Færch K; Martinez JA; Westerterp-Plantenga MS; Adam TC; Raben A Diabetes Care; 2022 Nov; 45(11):2698-2708. PubMed ID: 35696263 [TBL] [Abstract][Full Text] [Related]
13. A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM. Narayan KM; Hanson RL; Pettitt DJ; Bennett PH; Knowler WC Diabetes Care; 1996 Sep; 19(9):972-8. PubMed ID: 8875091 [TBL] [Abstract][Full Text] [Related]
14. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations]. Flórez H Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072 [TBL] [Abstract][Full Text] [Related]
15. Predictors of lifestyle intervention outcome and dropout: the SLIM study. Roumen C; Feskens EJ; Corpeleijn E; Mensink M; Saris WH; Blaak EE Eur J Clin Nutr; 2011 Oct; 65(10):1141-7. PubMed ID: 21587283 [TBL] [Abstract][Full Text] [Related]
16. Impaired glucose tolerance and NIDDM: does a lifestyle intervention program have an effect? Bourn DM; Mann JI; McSkimming BJ; Waldron MA; Wishart JD Diabetes Care; 1994 Nov; 17(11):1311-9. PubMed ID: 7821173 [TBL] [Abstract][Full Text] [Related]
17. Effects of sex, age and BMI on screening tests for impaired glucose tolerance. Gomyo M; Sakane N; Kamae I; Sato S; Suzuki K; Tominaga M; Kawazu S; Yoshinaga H; Tsushita K; Sato J; Sato Y; Tsujii S; Yoshida T; Seino Y; Usui T; Nanjo K; Hirata M; Kotani K; Hososako A; Kiyohara Y; Kuzuya H Diabetes Res Clin Pract; 2004 May; 64(2):129-36. PubMed ID: 15063606 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Li G; Zhang P; Wang J; An Y; Gong Q; Gregg EW; Yang W; Zhang B; Shuai Y; Hong J; Engelgau MM; Li H; Roglic G; Hu Y; Bennett PH Lancet Diabetes Endocrinol; 2014 Jun; 2(6):474-80. PubMed ID: 24731674 [TBL] [Abstract][Full Text] [Related]
19. Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study. Chen Y; Zhang P; Wang J; Gong Q; An Y; Qian X; Zhang B; Li H; Gregg EW; Bennett PH; Li G Diabetologia; 2021 Jun; 64(6):1279-1287. PubMed ID: 33608769 [TBL] [Abstract][Full Text] [Related]
20. [Prevalence of type II diabetes mellitus in population of Krakow]. Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]